Ocular complications in renal transplant recipients. 1973

J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007429 Intraocular Pressure The pressure of the fluids in the eye. Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002386 Cataract Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed) Cataract, Membranous,Lens Opacities,Pseudoaphakia,Cataracts,Cataracts, Membranous,Lens Opacity,Membranous Cataract,Membranous Cataracts,Opacities, Lens,Opacity, Lens,Pseudoaphakias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin
February 1992, Transplantation proceedings,
J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin
September 1975, The Western journal of medicine,
J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin
August 1977, Canadian Medical Association journal,
J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin
November 1998, Transplantation proceedings,
J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin
April 2023, JPMA. The Journal of the Pakistan Medical Association,
J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin
January 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin
February 2003, Transplantation proceedings,
J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin
July 2006, Advances in chronic kidney disease,
J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin
April 2000, Advances in renal replacement therapy,
J S Berkowitz, and D S David, and S Sakai, and H Shoji, and J S Cheigh, and R R Riggio, and K H Stenzel, and A L Rubin
January 2005, Transplantation proceedings,
Copied contents to your clipboard!